Chikungunya Virus Net is the web resource for anyone interested in chikungunya. Chikungunya virus (CHIKV) is an insect-borne virus, of the genus Alphavirus, that is spread by Aedes mosquitoes. Chikungunya infection causes fever and severe joint pain. Other symptoms include muscle pain, headache, nausea, fatigue and rash. The disease shares some clinical signs with dengue, and can be misdiagnosed in areas where dengue is common. There have been recent breakouts of chikungunya in Africa, Asia and the Indian subcontinent. In recent decades mosquito vectors of chikungunya have spread to Europe and the Americas. In 2007, disease transmission was reported for the first time in Europe. There is no cure for the disease. Treatment is focused on relieving the symptoms.

The objectives of Chikungunya Virus Net are to be the public and professional information resource for chikungunya and to serve as a network in the exchange of information and news related to chikungunya.

• Chikungunya VLP Vaccine Candidate Reports Positive Dosing Results - Vax Before Travel
  Fri, 22 Nov 2019 08:00 GMT
• Emergent BioSolutions shows positive results in chikungunya virus clinical trials - Homeland Preparedness News
  Mon, 25 Nov 2019 08:00 GMT
• Mosquito sterilization offers new opportunity to control chikungunya, dengue, and Zika - World Health Organization
  Thu, 14 Nov 2019 08:00 GMT
• Chikungunya Vaccine Candidate Delivered Excellent Study Results - PrecisionVaccinations
  Mon, 18 Nov 2019 08:00 GMT
• Valneva Reports Excellent Final Phase 1 Results for its Chikungunya Vaccine Candidate, Confirms Plans - GlobeNewswire
  Mon, 18 Nov 2019 08:00 GMT
• Thailand chikungunya cases top 10,000 for 2019 - Outbreak News Today
  Tue, 03 Dec 2019 10:27 GMT
• Sterilizing mosquitoes may be the answer to curb Zika, Dengue, Chikungunya, WHO reports - News-Medical.net
  Mon, 18 Nov 2019 08:00 GMT
• Chikungunya Vaccine Development May Rely On Immunologic Biomarkers Instead Of Traditional Trials - Pink Sheet
  Thu, 07 Nov 2019 08:00 GMT
• Thailand chikungunya cases top 9,000, Up dramatically over recent years - Outbreak News Today
  Sat, 09 Nov 2019 08:00 GMT
• Emergent BioSolutions Presents Positive Immunogenicity Results From Phase 2 Study of Its Investigational Chikungunya VLP Vaccine Candidate - BioSpace
  Fri, 22 Nov 2019 08:00 GMT
• At 659 cases, Pune accounts for 60% of chikungunya burden in state - Times of India
  Tue, 19 Nov 2019 08:00 GMT
• The ID Pipeline: FDA Activity From the Week of November 24, 2019 - Contagionlive.com
  Sat, 30 Nov 2019 16:01 GMT
• Infecting mosquitoes with bacteria led to dramatic drops in dengue in trials - STAT
  Thu, 21 Nov 2019 08:00 GMT
• Humanitarian Action for Children 2020 - Sudan - Sudan - ReliefWeb
  Thu, 05 Dec 2019 16:01 GMT
• Motherhood, Chikungunya but Sania Mirza 'enjoying the struggle' on her comeback mission - Times of India
  Fri, 29 Nov 2019 04:26 GMT

• PRO/AH/EDR> Chikungunya (08): Americas, Africa, Asia, Europe, comment
  Tue, 12 Nov 2019 13:47:29 -0500
  Chikungunya -- Honduras
  [Editorial]
  -----------
  "Doctor, I will never normally work and live again; joint pain prevents me that." This was expressed by a patient in La Virginia, Colombia 3 years after having been infected with chikungunya virus (CHIKV).
  After more than 5 decades of obscurity, probably due to lack of studies, many clinical consequences of CHIKV began to be reported, particularly rheumatic ones, after the outbreaks in Réunion Island and India (Javelle et al, 2015) during the epidemic wave that

• [Leptospirosis in patients with negative results for dengue, zika, and chikungunya in Jaen, Peru].
  
• Experience of the Arbovirus Death Investigation Committee in Ceará, Brazil, in 2017: advances and challenges.
  
• Dengue fever and chikungunya virus infections: identification in travelers in Uganda - 2017.